NCT01512758View on ClinicalTrials.gov

A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 6, 2012

Primary Completion Date

October 8, 2013

Study Completion Date

October 8, 2013

Conditions
Advanced Solid TumorsLymphomas
Interventions
DRUG

Alisertib

Alisertib enteric-coated tablets

Trial Locations (1)

169610

National Cancer Centre, Tiong Bahru

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY